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     ABSTRACT 
 
Relationship of the surface physicochemical characteristics of nanoparticles with their 
interactions with biological entities may provide critical information for nanomedicinal 
applications. In this work, we have presented the systematic synthesis of sub 50nm carbon 
nanoparticles (CNP) presenting neutral, anionic, and cationic surface headgroups. A subset of 
CNPs with ~ 10, 20, and 40nm hydrodynamic sizes are synthesized with neutral surface 
headgroups. 
The cellular internalization of these CNPs was systematically quantified for the first time in 
various stages of breast cancer cells (early, late and metastatic), providing a parametric 
assessment of charge and size effects. Distinct activities are noticed with these systems as they 
interact with various stages of the cancer cells. Our results indicated that a metastatic breast 
cancer could be targeted with a nanosystem presenting anionic phosphate groups. On the 
contrary, for patients with late stage cancer, drugs could be delivered with sulfonate 
functionalized carbon nanoparticles with higher probability of intracellular transport.  
This study will facilitate a better understanding of nanoparticle-biologic interaction and the 
integration of this knowledge with pathophysiology would help to engineer nanomedicine with 
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Myriad of nanoparticles have been developed for biological applications and a few of those have 
already been approved clinically to treat cancers. [1, 2] Despite some success, the unprecedented 
potential of nanomedicine has remained elusive. Failure in a clinical setup can be attributed to 
several factors, one of which is the lack of proper understanding of the mechanism of interaction 
of these agents with biological systems. [3-6] Relationship of the surface physicochemical 
characteristics of nanoparticles with their interactions with biological entities may provide 
critical information for nanomedicinal application. 
 Cellular internalization of nanoparticles is typically guided by penetration, adhesion, hemifusion 
and endocytosis. [7, 8, 9] Among these, endocytosis remains a fundamental feature of living 
cells, involved in several specialized functions, e.g. nutrients uptake, regulation of cell migration, 
immune system, etc. [10, 11] Endocytosis can be broadly classified into two mechanisms, 
phagocytosis and pinocytosis, [12-14] wherein the latter is the most common pathway utilized 
for entry in cells by the majority class of nanoparticles.  It is known that endocytosis is 
dysregulated in cancer. Studies indicate that endocytotic alterations in cancer cells may affect 
cell surface expression of critical molecules and significantly influences the cancer-relevant 
phenotypes, with potential implications for interventions to control cancer by modulating 
nanoparticle surface chemistry and other parametric characteristics. It is now well recognized 
that various signaling pathways do persist in the endocytic route and emerging evidence ties 




Metastasis, for instance, is a multistep process requiring cancer cell signaling, invasion, 
migration, survival, and proliferation through dynamic modulation of cell surface proteins by 
endocytosis. Studies have shown that the internalization of nanoparticles in cells are often 
dictated by their size, [15, 16, 17] functionality, [18, 19, 20] and surface charge. [21, 22] 
However, the mechanistic understanding of nanoparticle internalization dependent on the 
stepwise progression of the cancer leading to tumor formation and subsequent metastatis, still 
lacks depth.  
 
Our approach intends to borrow from the field of genetics to predict an individual’s response to a 
drug based on the histopathological information obtained from biopsy. (Figure 1.1) This may 
result in a diagnostic cohort for stratification of ‘right’ nanomedicine candidate relying on cancer 
phenotypes for improved efficacy and reduced toxicity.  Herein, we parametrically assess carbon 
nanoparticles based on size, charge and surface chemistry and stratify endocytic cellular uptake 
from pathophysiological differences. The choice of carbon as a nanoplatform was mainly chosen 
due to their ease of accessibility, low toxicity and facile surface chemistry. [23, 24] We report 
here the systematic synthesis of sub 50 nm carbon nanoparticles (CNP) presenting neutral, 
anionic, and cationic surface functionalities. A subset of CNPs with 10, 20 and 40 nm 
hydrodynamic sizes are also synthesized with neutral surface headgroups. The cellular 
internalization of these CNPs was systematically quantified for the first time in various stages of 
























Figure 1.1 A schematic and conceptual representation of personalized selection of nanoparticles 
from pathophysiologic (tumor biopsy) and phenotype dependent (cancer stages) and its 
correlation as a function of surface chemistry and size. 
 
A series of nanoparticles were prepared with cationic, anionic or neutral surface properties.  It is 
now well established that endocytosis is a physiological process that is modified in cancer by 
significantly altering phenotypes. Although our knowledge remains limited and the 
pathophysiological contributions of these endocytic alterations may not be wholly understood, 
we decided to study the major endocytic routes, i.e. clathrin, lipid-raft mediated, dynamin, and 
energy dependent pathways. Our results demonstrated fort he first time that carbon nanoparticles, 
as a function of their surface charge and particle diameter, typically favor a selective endocytic 
pathway depending on the progression of breast cancer. This understanding of surface 
characteristics and cancer stage-driven internalization of particle may improve the success of 









Agave nectar (18% glucose and 56% fructose by weight, Honey Tree’s® Organic Agave 
Nectar, MI, USA) was obtained from a local grocery store. Poly (ethylene glycol) (PEG, 
average Mn = 400, Mn =10,000 and Mn= 20,000), Polyethylenimine, branched (PEI, average 
Mw ≈ 25,000), Sucrose (≥99.5%), Sodium azide (NaN3, ≥99.5%), Nystatin, 2-Deoxy-D-Glucose 
(DOG, ≥98%) were purchased from Sigma-Aldrich (MO, USA) and used without further 
purification. Polyethylene glycol phosphate (PO4-, Mw=5000) was purchased from Chemicell 
(Berlin, Germany). Methoxy PEG Thiol (SH, ≥97%, Mw= 20,000) was purchased from JenKem 
Tech. (TX, USA). Polyethylene glycol monomethyl ether mesylate (SO3H, Mw=5000) and 
Chlorpromazine (CPM, 97%) were purchased from Santa Cruz Biotechnology (TX, USA). 
Dynasore (>99%) was purchased from Fisher Scientific (PA, USA). The 0.2 µM and 0.45 µM 
filters (Millex, Merck Millipore Ltd., Tullagreen, Carrigtwohill, County Cork, Ireland) were 
used wherever applicable. 
 
 
2.2 PREPARATION OF CARBON NANOPARTICLES 
 
Pristine CNPs were prepared by dissolving 250 mg of agave nectar in 2 ml of nanopure water 
(0.2 µM, 18 MΩ·cm). Then the aqueous solution was heated on a hot plate at 270 °C for roughly 
30 mins and re-suspended in 4 ml of nanopure water. Followed by 20 min probe sonication 




through a syringe filter with a 0.2 µm pore size (Millex®, Merck Millipore Ltd., County Cork, 
Ireland) prior to use.  
 
2.3 PREPARATION OF CARBON NANOPARTICLES BY PRE-PASSIVATION 
 
A mixture of agave nectar and polymer (PEGylated CNPs, CNP PO4, CNP SO3H, CNP SH) was 
taken in glass sample vial of 20 mL capacity. To this, nanopure water was added and solution 
was mixed well to form a homogenous mixture. The concentration ratio of agave nectar to 
polymeric passivating agent was maintained at 1:1 (w/w). For the nucleation process, a hot plate 
surface was maintained at 270 °C while glass vials were kept un-capped to allow the slow 
evaporation of water. The temperature was maintained for around 30 mins, which led to 
generation of brownish to black mass (varies with passivating agent). The reaction mixture 
changed color from light yellow to dark brown to black along the course of the heating process. 
The as-synthesized particle mass was suspended in 4 mL of nanopure water followed by 20 min 
probe-sonication (Q700TM, Qsonica Sonicators, CT, USA) (Amp: 1, on: 2 sec, off: 1 sec). 
Sonicated suspension was centrifuged at 12000 g for 20 min, followed by collecting the 
supernatant by filtering through a 0.22 µm syringe filter.  
2.4 PREPARATION OF CARBON NANOPARTICLES BY POST-PASSIVATION 
 
 
In order to make CNP-PEI, 10 µL of branched PEI solution (1mg/10µL) were added to 1 mg of 
CNPs. After vortexed and left at room temperature for 30 mins, the solution was centrifuged for 
30 min at 75,000 rpm at 4 °C (OptimaTM MAX-XP Ultracentrifuge, Beckman-Coulter, CA, USA) 




probe-sonicated for 2 mins (Amp: 1, On: 2 sec, Off: 1 sec). All CNP formulations were made 
same concentration (5mg/ml) before using for the study. 
2.5 DYNAMIC LIGHT SCATTERING  
 
The hydrodynamic size distribution of the nanoparticles was determined through dynamic light 
scattering measurements on Malvern Zetasizer ZS90 instrument (Malvern Instruments Ltd, 
United Kingdom) at fixed angle of 90o. A 10 µL of particle suspension was mixed with 990 µL 
of nanopure water to run the samples in DLS machine. A photomultiplier aperture of 400nm was 
used and the incident laser power was so adjusted to obtain a photon counting rate between 200 
and 300 kcps. Measurements for which the measured and calculated baselines of the intensity 
autocorrelation function were within 0.1% range were used for diameter values. All 
measurements were carried out in triplet of thirteen consecutive measurements. 
 
2.6 TRANSMISSION ELECTRON MICROSCOPY    
 
Prior to sample preparation of CNP’s for TEM imaging, the nanoparticles were mildly vortexed. 
A 10 µL of nanoparticle sample (~0.1 mg/mL) was drop cast on 200-mesh copper grid. After 
waiting for 1 min, the excess fluid was absorbed by lint free Kim wipes. The transmission 
electron micrographs were acquired on a JEOL 2100 Cryo TEM machine and imaged by Gatan 







2.7 ZETA POTENTIAL MEASUREMENTS  
 
Zeta potential (ζ) values were determined using a Malvern Zetasizer (Malvern Instruments Ltd, 
United Kingdom) of Nano series. The experiments were performed at 25°C and pH 7 at the light 
scattering mode in the phase analysis light scattering (PALS) mode following solution 
equilibration at 25 °C. Calculation of ζ from the measured nanoparticle electrophoretic mobility 
(µ) employed the Smoluchowski equation: µ = εζ/η where ε and η are the dielectric constant and 
the absolute viscosity of the medium, respectively. Measurements of ζ were reproducible within 
±2 mV of the mean value, given by 3 determinations of 15 data accumulations. 
 
 
2.8 UV-VIS AND FLUORESCENCE MEASUREMENTS  
 
 
Ultraviolet-visible (UV-Vis) absorbance of CNPs was recorded on GENESYSTM 10S UV-Vis 
Spectrophotometer (Thermo Scientific, MA, USA). Absorbance spectra were collected at an 
interval of 1 nm scanning from 200–900 nm. The emission spectra of fluorescence measurements 
were obtained through NanoDrop 3300 Fluorospectrometer (Thermo Scientific, MA, USA). The 
excitation wavelength was set to 365 nm and the wavelength covered an excitation range 











2.9 RAMAN AND FT-IR MEASUREMENTS  
 
  
Aqueous suspension of the nanoparticles was dried onto a MirrIR IR-reflective glass slides 
(Kevley Technologies, Chesterland, Ohio, USA) for Fourier Transform Infrared (FT-IR) 
measurements using a Nicolet Nexus 670 FTI-IR (Fredrick Seitz Material Research Laboratories 
(FSMRL), Urbana, Illinois, USA). For each measurement 100 × 100 µm images were collected at 
1 cm−1 spectral resolution with 64 scans per pixel and a 25 × 25 µm pixel size and individual 
spectra were corrected for atmospheric contributions. Raman spectra were acquired through 
dried samples described in the Infrared spectroscopy section in a reflection mode of Nanophoton 
Raman-11 (FSMRL). The excitation wavelength for all measurements was 532 nm and the 
power was set to 2% with a 60 s acquisition time. The Raman shift from 400 to 4000 cm−1 was 
collected at 1 cm−1 spectral resolution while the Laser light was focused through a 20× objective. 
 
2.10 NMR MEASUREMENTS 
  
 
 1H NMR measurements were performed on VARIAN UNITY 500 (Varian, Inc., Palo Alto, CA) 
spectrometer operating at 500 MHz equipped with 5 mm Nalorac QUAD probe. Chemical shifts 
were reported in ppm and referenced to the solvent proton impurities. Deuterium oxide (D2O) 
was used as the deuterated solvent for all the used samples. A 600 µl of sample was transferred 
to the NMR tube for acquiring chemical shifts. A total of 256 acquisitions were made and the 
data was processed and analyzed with MestRenova™ 8.1 software (Mestrelab Research SL; 









2.11 CONFOCAL MICROSCOPY STUDIES   
 
 
MCF-7 cells were plated on circular 22 mm glass microscope slides at a cell density of 400,000 
cells/slide in a volume of 200 µL of growth medium and placed in a six-well plate. The cells 
were incubated at 37 ˚C and 5% CO2 for 24 hours prior to treatment. The cells were washed 
twice with 1 ml of reconstituted medium and treated with a 10% v/v solution containing 100 µL 
of nanoparticle formulation and 900 µL of DMEM with 10% FBS. Following 4 hours of 
incubation, the cells were washed twice with DPBS, fixed with 4% w/v paraformaldehyde in 
DPBS, and mounted onto glass slides with DAPI-containing mounting medium. The confocal 
microscopy measurements were taken on the Zeiss LSM 700 (Peabody, MA, United States) and 
the samples were excited at 488 nm for the DAPI and 555 nm and 639 nm for the CNP 
measurements using suitable filters. 
 
2.12 MTT ASSAY 
 
The cytotoxic effect of various CNPs in different breast cancer cell-lines were investigated 
with a 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-
Aldrich, MO, USA). MCF-7, MDA-MB231, BT-549 and MCF-10a cells were plated in a 96-
well plate at a density of 10,000 cells per well (Greiner Cellstar® 96 well plates, Sigma-
Aldrich, MO, USA) and were allowed to grow for 24 h at 37 °C to reach around 80-85% cell 
confluence. Grown cells were then exposed with CNPs whose concentration was ranging from 
10, 5, 2.5, 1.25, 0.625, 0.31 and 0.15% (v/v).  Followed by a 44 h exposure time, 20 µL 
(5 mg/mL) of MTT solution was added to each well and cells were further incubated for 




(DMSO, ≥99%, MP Biomedicals, USA) was added to dissolve formazan crystals. Optical 
density of the samples was determined by Synergy HT (BioTek, USA) with a reference 
wavelength of 592 nm. The percentage cell viability was determined by the following 
equation: 
% Cell viability = [{(A592 treated cells) − (A592 background)} / {(A592 untreated cells) − 
(A592 background)}] x 100 
 
2.13 MIXED CELL CULTURE  
 
MCF-7 and MDA-MB231 cells (8000 per well) were mixed together in different percentages 
(50:50, 25:75 and 75:25) and plated in a 96 well plates. Cells were grown for 24h before being 
incubated with different endocytic inhibitors. Cells were incubated with inhibitors and CNPs as 
described above. All the treatments were performed in triplicate. At the end of the incubation 
period, growth media were aspirated and 200 µL of dimethyl sulfoxide (DMSO, ≥ 99%, MP 
Biomedicals, USA) was added to dissolve formazan crystals. Absorption of the samples was 
determined by Synergy HT (BioTek, USA) with a reference wavelength of 592 nm. 
 % Cell viability = [{(A592 treated cells) − (A592 background)} / {(A592 untreated cells) − 








2.14 INHIBITOR STUDIES 
 
MCF-7, MDA-MB231, BT-549 and MCF-10a cells (105) were plated in 96 well plates. Cells 
were grown for 24h before being incubated with different endocytic inhibitors. Inhibitor 
formulations were made with reconstituted medium having sodium azide, DOG (deoxyglucose), 
CPM (chlorpromazine), Nystatin and Dynasore at a concentration of 10 µM, 50 µM, 28 µM, 180 
nM and 80 µM, respectively, which were used as described in some previous reports [41,42,43]. 
Cells were incubated with inhibitors for 1h at ambient condition. Inhibitors were then replaced 
with CNPs suspensions in reconstutited medium at concentrations of 5% (v/v). All the treatments 
were performed in triplicate. Cells that had only inhibitor treatments were considered as negative 
controls whereas cells treated with only CNP formulations without any pre-inhibitor treatment 
were used as positive controls. The cytotoxic effect of CNPs were investigated with a 3-(4,5-
dime thylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma-Aldrich, MO, 
USA). Cells were further grown for 44 h and at the end of incubation, a 20 µL (5 mg/mL) of 
MTT solution was added to each well and cells were further incubated for another 4.5 h. After 
incubation, media were aspirated and 200 µL of dimethyl sulfoxide (DMSO, ≥ 99%, MP 
Biomedicals, USA) was added to dissolve formazan crystals. Absorption of the samples was 
determined by Synergy HT (BioTek, USA) with a reference wavelength of 592 nm. 
 % Cell viability = [{(A592 treated cells) − (A592 background)} / {(A592 untreated cells) − 






2.15 ENDOCYTIC BLOCKERS TO STUDY CELL INTERNALISATION OF CNPs 
Response to cellular entry of CNPs against endocytic blockers were studied by fold decrease in 
cell death or increase in cell viability. It measures how the cell viability values for different CNP 
formulations, changed with/without the presence of inhibitors. The values were calculated by the 
following formula: 
Fold increase in Cell viability = ((Cell viability of CNP in presence of inhibitor – Cell viability 
of CNP in absence of inhibitors) / Cell Viability of CNP in absence of inhibitors) 
 
2.16 STATISTICAL ANALYSIS 
Statistical analysis on various biological results was carried out by using one-way ANOVA 
method. CNP Pristine was treated as control and compared to other CNP formulations. Fold 
increase for the nanoparticle formulations was plotted as mean values ± standard deviation, n = 
3. Statistical analysis results were represented as * for p<0.05, ** for p<0.01, *** for p<0.001 











RESULTS AND DISCUSSIONS 
 
3.1 CARBON NANOPARTICLES SYNTHESIS  
 
In this work, CNPs were prepared using two different strategies which included pre-and post-
passivation. [23] In both of these techniques, the carbon core was synthesized from the agave 
nectar, a natural carbohydrate mainly containing glucose, fructose, and other carbohydrate 
sources. The surface of the carbon core was passivated with either linear (PEG’s) or branched 
(PEI, etc.) organic macromolecules for the synthesis of both pre- and post-passivated 
nanoparticles. Macromolecule passivated carbon nanoparticles (CNP), along with pristine CNPs 
were characterized by physico-chemical techniques.  
 
3.2 PHYSIOCHEMICAL CHARACTERIZATIONS  
 
Figure 3.1 A, B depict the distribution of hydrodynamic diameter of CNPs and the corresponding 
data has been summarized in Table 3.1 calculated from the dynamic light scattering (DLS) 
measurements. It was interesting to note that PEGs, PO4, SO3H, SH and PEI passivated CNPs 
exhibited their hydrodynamic diameter in the range of 8-40 nm. This could be due to the possible 
cloaking of the polymer around the carbon core. In addition to DLS measurements, Transmission 




anhydrous state morphologies. Representative TEM images for CNP, CNP PO4, CNP SH, CNP 











Table 3.1 Dynamic light scattering analysis and zeta potential measurements of different CNPs 








CNP Pristine 49±10 -22±01 
CNP PEG400 33±09 -20±05 
CNP PEG10K 17±04 -08±01 
CNP PEG20K 08±01 -11±01 
CNP PEI 41±04 +19±02 
CNP PO4 26±07 -11±02 
CNP SO3H 25±10 -21±02 





Figure 3.1 (A, B) Hydrodynamic size distribution for pristine CNP and passivated CNPs using 
dynamic light scattering.  
 
Figure 3.2 Transmission electron micrographs of the prepared nanoparticles; (A) CNP, (B) CNP 





UV-Vis absorption spectra of pristine and passivated CNPs were carried out in the range of 250-
750 nm as shown in Figure 3.3. The characteristic strong peak in pristine CNP appeared at ~280 
nm along with a weak broad peak at 350 nm. Interestingly, this absorption spectrum remained 
more or less unaltered in CNP passivated by anionic polymers. On the contrary, 280 nm peak of 
CNP tends to become much broader/distorted when passivated with cationic polymers. A further 
investigation is needed to understand the exact effect of surface passivation over the absorption 
response of CNPs. The fluorescence measurements were carried out by exciting the synthesized 
CNP’s at 360 nm (λex) and tracking their emission from 430 to 800 nm (λem range). Figure 3.4 
showed the high fluorescence intensity of pristine CNP which gets reduced when it’s passivated 
with either anionic or cationic polymers.  Interestingly, fluorescence intensity of CNPs 
passivated with macromolecules exhibiting negative surface charge (PO4) were much higher 
compared to CNP’s passivated with macromolecules with positive surface charges (PEI). Such 
observation could be attributed to the different surface chemistries on the nanoparticle surface. 
The negative zeta potential on the surface of pristine CNP (no surface coating or passivating 
agent) could be attributed to the presence of over-abundance of carboxyl, hydroxyl and carbonyl 
groups on its surface as shown in Figure 3.5 and Table 3.1. Subsequent passivation of pristine 
CNP with polymer macromolecules (linear or branched) lead to an increase in its zeta potential 
value. A negative zeta potential was reported for CNP’s passivated with neutral or anionic 
polymers (PEG’s, PO4, SO3H, SH) however, CNP’s passivated with cationic polymers (PEI) 
exhibited positive zeta potential values. It supported the hypothesis that retention of 





Figure 3.3 UV-Vis spectroscopic measurements for pristine and passivated CNPs. The 
characteristic strong peak in pristine CNP appeared at ~280 nm along with a weak broad peak at 
350 nm. Interestingly, this absorption spectrum remained more or less unaltered in CNP 
passivated by anionic polymers. On the contrary, 280 nm peak of CNP tends to become much 
broader/distorted when passivated with cationic polymers. A further investigation is needed to 









Figure 3.4 Fluorescent measurements for bare and functionalized CNPs. The fluorescence 
measurements were carried out by exciting the synthesized CNP’s at 360 nm (λex) and tracking 
their emission from 430 to 800 nm (λem range). It showed high fluorescence intensity of pristine 
CNP which is reduced when it is passivated with either anionic or cationic polymers. 
Interestingly, fluorescence intensity of CNPs passivated with macromolecules exhibiting 
negative surface charge (PO4) was much higher compared to CNP’s passivated with 
macromolecules with positive surface charges (PEI). Such observation could be attributed to the 







Figure 3.5 Electrophoretic zeta potential measurements for pristine and passivated CNPs 
prepared via pre- and post-passivation routes. 
 
For accessing the surface chemistry of CNPs, Raman and FT-IR spectroscopic studies were 
performed. A Raman spectra of amorphous carbon materials is usually characterized by the 
presence of ‘G’ (graphitic) and ‘D’ bands (disordered graphitic) bands.[24] The D band (sp3 
hybridized) is often referred to as the disorder band or the defect band and is associated with the 
vibration of carbon atoms with dangling bonds in the terminal plane of the disordered graphite of 
amorphous carbon. The G band (sp2 hybridized), on the other hand, is related to the vibration of 
carbon atoms in a two dimensional hexagonal lattice. The ratio of the intensities of the two 




Raman spectra of pristine CNP and functionalized CNP’s (Figure 3.6A) showed that IG/ID ratio is 
highest for pristine CNP and eventually falls down when coated with polymer macromolecules. 
It was also interesting to note that IG/ID ratio is greater than 1 in CNP passivated with some 
anionic polymers (PO4-, SO3H, SH) which clearly indicated the presence of more graphitic 
domains over diamond-like domains. In contrast, IG/ID ratio falls below 1 in CNP passivated by 
cationic polymer (PEI), due to the presence of more diamond-like domains over graphitic 
domains.  
 FT-IR spectra of Pristine and passivated CNP’s were obtained as shown in Figure 3.6B. 
From the infra-red spectrum of Pristine CNP, we notice a broad peak that is centered around 
3450 cm-1. It also exhibits asymmetric stretching band, which corresponds to methyl 
functionalities (naCH3) at at 2900 cm-1 and methylene stretching band (nsCH2) at 2820 cm-1. We 
also observe the C=O stretching band is obtained at 1750 cm-1. The presence of hydrophilic 
groups on its surface results in an increased aqueous suspendability. Furthermore, passivated 
CNP’s were found to display spectra which included features of both the carbon core as well as 
the macromolecule with which it was passivated. We also observed carbonyl stretching (–C=O) 
and broad O-H and S-H vibrations for CNP SH and C-H (stretch and bend), carbonyl stretching 
(-C=O), S-H stretch and narrow O-H vibrations for CNP SO3H. For CNP PO4, a C-H and PO43- 
stretching and with narrow O-H vibrations and for CNP PEG20K, broad O-H vibrations and C-
H, C-O, C-O-C stretching was observed. 
Surface chemistries were further confirmed by 1H NMR spectroscopy studies. Experiment was 
carried out on the 500 MHz machine using a representative nanoparticle system CNP-SO3H. 
NMR peaks for the passivating macromolecules (Figure 3.7 and Figure 3.8) compared with data 




control spectrum to compare with passivated CNP. It was clearly observed that the chemical 
features from PEG SO3H have remained intact even after carbonization, confirming that the 
moieties could effectively function in the follow- up experiments. 
 
 
Figure 3.6 (A) Raman spectra of pristine CNP and CNPs passivated with PO4, SO3H, PEI and 
SH respectively; (B) FT-IR spectra of pristine CNP and CNPs passivated with PO4, SO3H, PEG 







Figure 3.7 1H-NMR spectra of CNPs, comparing parent macromolecule PEG SH with surface 
passivated CNPs (CNP SH) showing the retention of peaks from PEG SH (marked with the 




Figure 3.8 1H-NMR spectra of CNPs, comparing parent macromolecule PEG SO3H with surface 
passivated CNPs (CNP SO3H) showing the retention of peaks from PEG SO3H (marked with the 





3.3 MECHANISMS OF CELLULAR ENTRY IN CELLS OF DIFFERENT CANCER STAGES 
Cellular toxicity of CNPs in non-tumorigenic breast cells and tumorigenic breast cancer cells 
lines were evaluated by using MTT Assay (Figure 3.9). It works on the premise that decrease in 
mitochondrial respiration can be directly correlated to decrease in live cell population. This 
respiration eventually leads to mitochondrial oxidation, following which an added MTT reduces 
to form blue colored crystal of formazan. Concentration of the produced formazan crystals are 
found to be directly proportional to live population of cells, which gets decreased when cellular 
toxicity of CNPs increase. It was found that non-passivated CNPs do not have any considerable 
selectivity toward any of the used cell lines. Experiments were performed using CNPs at a 
concentration of 5% (v/v) with reconstituted growth medium. Cellular toxicity of nanoparticles 
generally correlates with delivered amount to intracellular compartment. The efficiency of being 
taken up and their routes for cellular entry can be used to analyze surface chemistry correlation 
for various CNPs to different stages of breast cancer. Results from the study would be able to 
generate a library of surface chemistries beneficial to deliver therapeutics using CNPs in 
different stages of cancer which could probably be extrapolated to other nanoparticle systems 
too. Studies were performed by blocking the selective endocytic entry path followed by CNP 
treatment to observe after effect of cellular entry of CNPs. Uptake of CNPs in MCF-10A (non-
tumorigenic breast cell line), MCF-7 (early stage breast cancer cell line), MDA-MB231 (late 
stage breast cancer cell line), BT-549 (metastatic breast cancer cell line) and heterogeneous 
mixture of MCF-7 and MDA-231 cells at ratio of 25:75, 50:50 and 75:25 were used to verify the 
route of cellular entries and their variation from non-cancer to different stages of cancers. Use of 
normal breast cells facilitates the comparison profile which would provide a background on the 




for uniform, quantified effect on all cell populations and have no considerable toxicity in short 
period incubations. They also and do not affect the actin cytoskeleton post treatment. [27,28] It was 
anticipated that a particular inhibitor would block a specific endocytic route of entry and 
consequently any CNPs entering the cells via that pathway. This in turn would decrease the cell 




Figure 3.9 (a) MTT Assay for evaluation of cytotoxic effects of pristine CNP and functionalized 
CNP’s in (A) MCF-10A, non-tumorigenic breast cells; (B) MCF-7 breast cancer cells. 
Experiments were performed in the above cell-lines after incubation for 48 h at various 







Figure 3.9 (Cont.) (b) MTT Assay for evaluation of cytotoxic effects of pristine CNP and 
functionalized CNP’s in (C) MDA-MB231 breast cancer cells; (D) BT-549 breast cancer cells. 
Experiments were performed in the above cell-lines after incubation for 48 h at various 
concentrations (20, 10, 5, 2.5, 1.25 and 0.625 %v/v). 
 
Learning this expected behavior of cells post incubation, inhibitors with different functions were 
used. It included a mixture of sodium azide (NaN3) and 2-deoxyglucose (DOG), which helped in 
inhibiting glycogenosis and cellular respiration respectively via energy dependent uptake.[29,30,31] 
The analysis of clathrin dependent entry was outlined using Chlorpromazine (CPM), a cationic 
amphiphilic drug. It was supposed to reduce the formation of clathrin-coated pits due to a 
reversible translocation of clathrin and its adapter proteins from the plasma membrane to 
intracellular vesicles. [32,33,34] Dynasore has been used to understand the inhibition of dynamin 




which dismantles caveolae and cholesterol in the membrane, has been employed to study 
clathrin-independent inhibition of endocytosis.[37,38]  
To investigate the mechanism of entry 10 x 103 cells were plated in a 96 well plate for 24h and 
allowd to reach a confluency of around 80%. Cells were further incubated with various inhibitors 
for 1h (Table 3.2). Cells were incubated with solution of NaN3 (10 mm) and DOG (50 mM) or 
CPM (28 nM), Nystatin (180 nM) and Dynasore (80 µM) for 1h. Cell medium was further 
replaced with 5% (v/v) of CNPs in respective reconstituted medium for 48h before performing 
the MTT assay. Particular attention was given to parametric assessment as a function of surface 
charge and nanoparticle hydrodynamic radii to understand their signature in entry, selectivity or 
inhibitory routes.   
 








NaN3 / DOG (37°C) ATP depletion 10 mM / 50 mM 1h 
NaN3 / DOG (4°C) ATP depletion + slows down 
metabolism 
10 mM / 50 mM 1h 
CPM Inhibits clathrin mediated 
endocytosis 
28 nM 1h 
Nystatin Inhibits lipid-raft mediated 
endocytosis 
180 nM 1h 
Dynasore Inhibits dynamin-dependent 
endocytosis 





For non-cancerous breast cells (MCF-10A), CNP passivated with a cationic or anionic polymer 
(PEI, -SH, -SO3H, -PO4) followed predominantly a clathrin-mediated internalization pathway.  
(Figure 3.10) Study was extended to primary stage breast cancer cells (MCF-7), and was found 
that lower molecular weight (Mw) PEGylated CNP (CNP PEG400), entered the cells via energy 
dependent pathway, clathrin-mediated pathway and dynamin-dependent pathway while higher 
Mw PEGylated CNPs (CNP PEG10K, CNP PEG20K) preferred entering the cells via clathrin-
mediated pathway.  Interestingly, a high level of selectivity was noticed for CNP SO3H, which 
was found to be internalized via energy dependent pathway. (Figure 3.11) However, it was found 
that none of the remaining positively, negatively or neutral CNPs favored any of the investigated 
pathways.   
In order to confirm that endocytic inhibitors are truly in function, the incubation temperature was 
lowered to 4°C while incubating cells with NaN3/DOG. This alteration expectedly resulted in 
lowering of the efficacy of the inhibitor, which consequently led to an increase in cellular entry 
compared to physiological temperature (37 °C). In the case of PEGylated CNPs, lowering the 
temperature resulted in a further increase of cellular entry for only CNP PEG10K while no effect 
was noticed for CNP PEG400 and CNP PEG20K. The rest of the CNP’s exhibited no considerable 
effect for the presence of NaN3/DOG except CNP SO3H.  A representative confocal study was 
performed to visualize the entry of CNPs and corroborated the cell viability results in primary 
breast cancer cells. It was found that using CNP PEG10K and CNP SO3H could enter to a higher 
extent in MCF-7 cells, presumably through more than one endocytic routes i.e. clathrin- and 
energy-dependent pathways as previously demonstrated by our MTT assay (Figure 3.12). 




to any of the used inhibitors under investigation. It clearly indicated a non-specific 
internalization route for MCF-7 cells. On the contrary, in case of CNP SH, no significant level of 
nanoparticle fluorescence (green) was noticed inside the cells. We may conclude that while 
cellular internalization of PEG and sulfonate functionalities get facilitated via specific endocytic 
routes, CNP presenting thiols on their surface greatly diminish the entry in early stage breast 
cancer cells. 
 
Figure 3.10 Cell viability of different nanoparticle formulations in the presence of endocytic 
inhibitors is shown. MCF-10A cells (10,000 per well) were plated in 96 well plates for 24h 
before performing the treatment. Cells were first incubated with different endocytic inhibitors, 
(A) NaN3/DOG at 37°C, (B) chlorpromazine, (C) dynasore, (D) nystatin for 1h followed by the 
addition of CNPs. Experiments were performed in triplicates. Statistical analysis was performed 
using One-way ANOVA where CNP Pristine was taken as the control column and compared with 
other nanoparticles. Cell viability of the nanoparticles was plotted as Mean±Standard Deviation, 





Figure 3.11 Cell viability of different nanoparticle formulations in presence of endocytic 
inhibitors is shown. MCF-7 cells (10000 per well) were plated in 96 well plates for 24h before 
performing the treatment. Cells were first incubated with different endocytic inhibitors, (A) 
NaN3/DOG at 37°C, (B) chlorpromazine (C) dynasore (D) nystatin for 1h followed by the 
addition of CNP formulations. Experiments were performed in triplicates. Statistical analysis was 
performed using One-way ANOVA where CNP pristine was taken as the Control column and 
compared with other nanoparticle formulations. Cell viability of the nanoparticle formulations 
was plotted as Mean± Standard Deviation, N=3 and * means p<0.05, ** means p<0.01, *** 




































Figure 3.12 (A) Fluorescence confocal microscopy images of MCF-7 cells (1) untreated or (2) 
treated with CNP Pristine, CNP PEG10K, CNP SO3H and CNP SH. Confocal images studied 
under (A) fluorescence with DAPI, (B) CNPs excited at 488 nm, (C) DIC images and (D) 
superimposed images; and (B) analysis of confocal images using ImageJ and calculating the 





For the late stage breast cancers, representative MDA-MB231 cells were used to reveal the 
prominence of lipid-raft mediated pathway for CNPs irrespective of their surface charge or 
particle size. [40] MDA-MB-231 is an invasive, estrogen-independent, late-stage metastatic and 
well-differentiated breast cancer cells. Interestingly, pristine CNP did not respond to either lipid-
raft mediated pathway or any of the other investigated pathways. (Figure 3.13) This behavior is 
in sharp contrast with the early stage breast cancer cells. Among various PEGylated CNPs, CNP 
PEG400 showed a higher tendency for cell uptake via lipid-raft mediated path. This observation 
was presumably due to a better association of lower molecular weight PEG with lipid raft 
although further dedicated studies would be required to confirm this. The presence of phosphate 
groups relied mostly on lipid-raft mediated pathway, while no such selectivity was seen for CNP 
SO3H (negative). It was also found that positively charged CNPs entered the cells through a 
lipid-raft mediated pathway. A pronounced cell uptake could be achieved at low temperature of 









Figure 3.13 Cell viability of different nanoparticle formulations in presence of endocytic 
inhibitors is shown. MDA-MB231 cells (10,000 per well) were plated in 96 well plates for 24h 
before performing the treatment. Cells were first incubated with different endocytic inhibitors, 
(A) NaN3/DOG at 37°C, (B) chlorpromazine, (C) dynasore, (D) nystatin for 1h followed by 
addition of CNPs. Experiments were performed in triplicates. Statistical analysis was performed 
using One-way ANOVA where CNP Pristine was taken as the Control column and compared 
with other nanoparticles. Cell viability of the nanoparticle formulations was plotted as Mean± 
Standard Deviation, N=3 and * means p<0.05, ** means p<0.01, *** means p<0.001 and **** 
means p<0.0001. 
For scenario of metastatic cancer, BT-549, a representative triple negative cell line was selected 
from a papillary, invasive ductal tumor which is originally known to metastasize to three of 
seven regional lymph nodes. We noticed that pristine CNP entered the cells via clathrin mediated 
pathway while high Mw PEGylated CNPs (CNP PEG10K and CNP PEG20K) followed multiple 




energy dependent pathway. It was observed that positively charged CNPs could internalize 
metastatic breast cancer cells through clathrin- and dynamin-dependent pathway, whereas 
negatively charged CNPs did not show any specific trends for entry. While CNP SH did not 
show any significant variation via investigated pathways similar to primary and advanced stage 
breast cancer cells. 
 
Figure 3.14 Cell viability of different Nanoparticle formulations in presence of endocytic 
inhibitors is shown. BT-549 cells (10000 per well) were plated in 96 well plates for 24hrs before 
performing the treatment. Cells were first incubated with different endocytic inhibitors, (A) 
NaN3/DOG at 37°C, (B) chlorpromazine, (C) dynasore, (D) nystatin for 1h followed by addition 
of CNP formulations. Experiments were performed in triplicates. Statistical analysis was 
performed using One-way ANOVA where CNP Pristine was taken as the Control column and 
compared with other Nanoparticle formulations. Cell viability of the nanoparticle formulations 
was plotted as Mean±Standard Deviation, N=3 and * means p<0.05, ** means p<0.01, *** 




Table 3.3 Analysis of cellular internalization of CNPs via NaN3/DOG at 4°C (ATP depletion and 
slowing down of metabolism) by comparing it with NaN3/DOG at 37°C (ATP depletion alone).  
Each of the CNPs were analyzed using power analysis and mean fold increase ≥ 1.35 was 
considered to be significant and designated by ‘+’ and mean fold increase < 1.35 was designated 
as ‘- ‘, meaning no significant inhibition. 
Nanoparticle   MCF-7 MDA-
MB231 
BT-549 
CNP Pristine - - - 
CNP PEG400 - + + 
CNP PEG10K + - + 
CNP PEG20K - + + 
CNP PEI - + - 
CNP PO4 - - - 
CNP SO3H + - - 
CNP SH - - - 
 
 
3.4 MECHANISMS OF CELLULAR ENTRY IN MIXED POPULATION OF DIFFERENT 
STAGED CANCER CELLS 
 
 
We realize that in practice, tumors would be represented more realistically by studying a 
heterogeneous mixture of cancer cell population of different stages. Towards this aim, the first 
phase of study was repeated with heterogeneous mixtures of MCF-7 and MDA-MB231 cells in 
different ratios of number/number, i.e. 25:75, 50:50 and 75:25, respectively. For a 50:50 mixture 
of MCF-7 and MDA-MB231 cells, pristine CNPs predominantly followed clathrin-mediated 
pathway for entry while PEGylated CNPs, utilized a combination of all the investigated 




dependent and lipid-raft mediated pathway entry, unlike CNP PO4, which followed both energy 
dependent and lipid-raft mediated route for entry. Finally, CNP SH showed to favor all the 
investigated routes for internalization (Figure 3.18). The effect on cell morphology and density 
for CNPs, after inhibitor treatment, was also obtained via bright field imaging (Figure 3.15). 
Interestingly for a mixture of MCF-7 and MDA-MB231 in the ratio of 25:75 (% number), we 
observed (Figure 3.16) that pristine CNP used energy-dependent, dynamin dependent and lipid-
raft mediated pathway which also involved energy dependent path for entry to higher population 
ratio of MCF-7 in mixed population of MCF-7 and MDA-MB231 (75:25) (Figure 3.17). In the 
mixture of 50:50, it was only responsive to clathrin-mediated entry and non-responsive to other 
modes of entry. So, an increase in the percentage of well-differentiated MDA-MB231 (or 
decrease of early stage MCF-7) cell population might have led to a change in endocytic route for 
entry of bare CNPs. For PEGylated CNPs, CNP PEG400 showed to follow all the investigated 
pathway for entry, whereas CNP PEG10K used both dynamin-dependent and lipid-raft mediated 
entry in mixed cells with 25:75 and 75:25 population ratio, it followed all the investigated 
pathways for 50:50 ratios. To analyze the effect a particular inhibitor play in endocytosis of 
different CNPs in cancer cell lines of different stages, Figure 3.19-Figure 3.22 were plotted. In 
case of cationic CNPs, CNP PEI was seen to follow all the investigated pathways for 
internalization in the cells. For anionic CNPs, all the investigated pathways were generally found 
to be activated in mixture with high MCF-7 population while the presence of high MDA-MB231 
dictates the anionic CNPs cellular entry through lipid-raft. Thus, overall, the presence of MDA-
MB231 cell population dominated the internalization pathway of CNPs irrespective of their size 
























Figure 3.15 Bright field images of MCF-7 and MDA-MB231 cells mixed in 50:50 ratio (A) 
untreated (B) treated with inhibitor for 1 h, followed by additional incubation with CNP 
formulations (C), having a concentration of 5% v/v for 48h. 8000 cells were plated in 96 well 






Figure 3.16 Cell viability of different nanoparticle formulations in presence of different 
endocytic inhibitors is shown. A mixture of MCF-7 and MDA-MB231 cells (8,000 cells per 
well) in the ratio of 25:75 (v/v) were plated in 96 well plates for 24h before performing the 
treatment. Cells were first incubated with different endocytic inhibitors, (A) NaN3/DOG at 37°C, 
(B) chlorpromazine (C) dynasore (D) nystatin for 1 h followed by addition of CNPs. 
Experiments were performed in triplicates. Statistical analysis was performed using One-way 
ANOVA where CNP pristine was taken as the control column and compared with other 
Nanoparticle formulations. Cell viability of the nanoparticles was plotted as Mean± Standard 








Figure 3.17 Cell viability of different nanoparticle formulations in presence of different 
endocytic inhibitors is shown. A mixture of MCF-7 and MDA-MB231 cells (8,000 cells per 
well) in the ratio of 75:25 (v/v) were plated in 96 well plates for 24h before performing the 
treatment. Cells were first incubated with different endocytic inhibitors, (A) NaN3/DOG at 37°C, 
(B) chlorpromazine (C) dynasore (D) nystatin for 1 h followed by addition of CNPs. 
Experiments were performed in triplicates. Statistical analysis was performed using One-way 
ANOVA where CNP pristine was taken as the control column and compared with other 
Nanoparticle formulations. Cell viability of the nanoparticles was plotted as Mean± Standard 








Figure 3.18 Cell viability of different nanoparticle formulations in presence of different 
endocytic inhibitors is shown. A mixture of MCF-7 and MDA-MB231 cells (8,000 cells per 
well) in the ratio of 50:50 (v/v) were plated in 96 well plates for 24h before performing the 
treatment. Cells were first incubated with different endocytic inhibitors, (A) NaN3/DOG at 37°C, 
(B) chlorpromazine (C) dynasore (D) nystatin for 1 h followed by addition of CNPs. 
Experiments were performed in triplicates. Statistical analysis was performed using One-way 
ANOVA where CNP pristine was taken as the control column and compared with other 
Nanoparticle formulations. Cell viability of the nanoparticles was plotted as Mean± Standard 






All the results obtained from inhibitor studies were in terms of cell viability (Figure 3.10- Figure 
3.14). So to get information about the internalization of these CNPs in cancer cells lines, they 
have to be converted to fold increases values first, which are shown below.  
 
 
Figure 3.19 MTT assay for evaluation of inhibitor efficiency of NaN3/DOG (at 37°C) for 
different CNP formulations (5% v/v) in (A) MCF-10a, (B) MCF-7, (C) MDA-MB231, (D) BT-
549, (E) 25:75 mixtures of MCF: MDA-MB231 (F) 50:50 mixtures of MCF: MDA-MB231 (G) 
75:25 mixtures of MCF: MDA-MB231 was done, consequently from which fold increase was 
obtained. A non-synchronized population of cells (10,000 or 8,000 cells per well) was plated in 
96 well plates for 24h before performing the treatments. Cells were first incubated with inhibitor, 
NaN3/DOG (10mM/50 mM) for 1h followed by CNP addition. Experiments were performed in 






Figure 3.20 MTT assay for evaluation of inhibitor efficiency of chlorpromazine (CPM) (at 37°C) 
for different CNP formulations (5% v/v) in (A) MCF-10a, (B) MCF-7, (C) MDA-MB231, (D) 
BT-549, (E) 25:75 mixtures of MCF: MDA-MB231 (F) 50:50 mixtures of MCF: MDA-MB231 
(G) 75:25 mixtures of MCF: MDA-MB231 was done, consequently from which fold increase 
was obtained. A non-synchronized population of cells (10,000 or 8,000 cells per well) was plated 
in 96 well plates for 24h before performing the treatments. Cells were firstly incubated with 
inhibitor, NaN3/DOG (10mM/50 mM) for 1h followed by CNP addition. Experiments were 





Figure 3.21 MTT assay for evaluation of inhibitor efficiency of dynasore (at 37°C) for different 
CNP formulations (5% v/v) in (A) MCF-10a, (B) MCF-7, (C) MDA-MB231, (D) BT-549, (E) 
25:75 mixtures of MCF: MDA-MB231 (F) 50:50 mixtures of MCF: MDA-MB231 (G) 75:25 
mixtures of MCF: MDA-MB231 was done, consequently from which fold increase was obtained. 
A non-synchronized population of cells (10,000 or 8,000 cells per well) was plated in 96 well 
plates for 24h before performing the treatments. Cells were first incubated with inhibitor, 
NaN3/DOG (10mM/50 mM) for 1h followed by CNP addition. Experiments were performed in 







Figure 3.22 MTT assay for evaluation of inhibitor efficiency of nystatin (at 37°C) for different 
CNP formulations (5% v/v) in (A) MCF-10a, (B) MCF-7, (C) MDA-MB231, (D) BT-549, (E) 
25:75 mixtures of MCF: MDA-MB231 (F) 50:50 mixtures of MCF: MDA-MB231 (G) 75:25 
mixtures of MCF: MDA-MB231 was done, consequently from which fold increase was obtained. 
A non-synchronized population of cells (10,000 or 8,000 cells per well) was plated in 96 well 
plates for 24h before performing the treatments. Cells were firstly incubated with inhibitor, 
NaN3/DOG (10mM/50 mM) for 1h followed by CNP addition. Experiments were performed in 
triplicates. Fold Increase ≥ 1.35 was considered to be significant. 
 
The mode of endocytosis entry of CNPs could be corroborated with cell viability results by 
creating a heat map. (Figure 3.23) A mean fold-increase value greater than or equal to 1.35 was 




internalization route. These fold-increase values would lie on a higher confidence interval (~ 
95%), as calculated by confidence interval calculator by Mccallum-layton, thereby making 
subsequent comparison amongst rest of data sets significant. 
 
It was observed that endocytic entry in late stage breast cancer (MDA-MB231) cells followed a 
lipid-raft pathway irrespective of the size and surface chemistry. Interestingly, in metastatic cells 
(BT-549) most of the particles followed a combination of two or more pathways for 
internalization, thereby leading to a higher likelihood of internalization of the nanoparticles. 
However, for early stage breast cancer (MCF-7) cells, no such general trend was observed. 
Furthermore, for heterogeneous mixture of MCF-7 and MDA-MB231 cells, it was observed that 
all tested endocytic uptake routes were active, thereby allowing CNPs to internalize via multiple 
endocytic pathways, a trend which was not followed by most of the CNPs in either MCF-7 or 
MDA-MB231 cells alone. In addition, it could be concluded that as the cancer progresses from 
early to metastatic stage via late-stage, anionic CNPs and neutral CNPs enter the cells more 






















Figure 3.23 Heat map analysis to show the effect of Inhibitors on uptake of CNPs for different 
breast cancer cell lines was plotted. Fold Increase values between 1.35-2.0 (green) and greater 
than 2 (red) were considered as significant inhibitor in uptake, whereas Fold increase values less 







Figure 3.24 Parametric evaluation of surface charge and progression of breast cancer effects on 
internalization of CNPs. As the cancer progresses from initial stages to metastatic, more number 











CONCLUSION AND FUTURE OUTLOOK 
 
 
4.1 CURRENT PERSPECTIVE 
Herein, we have reported a systematic synthesis of sub 50nm carbon nanoparticles (CNP) 
presenting neutral, anionic, and cationic surface headgroups. A subset of CNPs with ~ 10, 20, 
and 40nm hydrodynamic sizes are synthesized with neutral surface headgroups. Comprehensive 
physiochemical characterizations were performed to confirm the successful synthesis of these 
nanoplatforms. The cellular internalization of these CNPs was systematically quantified for the 
first time in various stages of breast cancer cells (early, late and metastatic), providing a 
parametric assessment of charge and size effects. Distinct activities are noticed with these 
systems as they interact with various stages of the cancer cells.  
 
The main findings can be summarized as follows:  
• Distinct activities are noticed with these nanoparticles based systems as they interact 
with various stages of cancer cells in a different way. For late stage cancer cells 
(represented using MDA-MB231cells), lipid raft mediated endocytosis route was 
predominant, whereas for metastatic cancer cells (represented using BT-549cells), a 
combination of clathrin-mediated and energy dependent pathways were responsible for 
the internalization. However, in case for non-tumorigenic cells (represented by MCF 10a 
cells), clathrin-mediated entry was observed. 




presenting anionic phosphate groups or pegylated group having a molecular weight of 
20K Da. On the contrary, for patients with late stage cancer, drugs could be delivered 
with sulfonate functionalized carbon nanoparticles with higher probability of 
intracellular transport.  
 
4.2 FUTURE OUTLOOK 
One of the key translational challenges has been to better stratify nanotherapeutics based on 
patients’ pathophysiologic information collected from biopsy. This work takes an exactitude 
nanomedicine approach to predict how well drug-loaded nanoparticles will accumulate in a 
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